A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CAP / captopril

[Related PubMed/MEDLINE]
Total Number of Papers: 152
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CAP  (>> Co-occurring Abbreviation)
Long Form:   captopril
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 2D-Single-crystal hexagonal gold nanosheets for ultra-trace voltammetric determination of captopril. SCHGNSs
2019 Application of a nano-structured molecularly imprinted polymer as an efficient modifier for the design of captopril drug selective sensor: Mechanism study and quantitative determination. CPE, GCE, MIP
2019 Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/beta-catenin and Jak2/Stat3 pathways. ACEI, ANP, AscAo, ELISA, HBWR, IL-6, NT-proBNP, p-Jak2, p-Stat3, TAC, TNF-alpha
2019 Neuropeptidase activity in the frontal cortex of Wistar-Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study. PRO, SHRs, WKY
2019 Sustained Captopril-Induced Reduction in Blood Pressure Is Associated With Alterations in Gut-Brain Axis in the Spontaneously Hypertensive Rat. BP, SHR
2019 Synthesis of Silica-Coated Magnetic Hydroxyapatite Composites for Drug Delivery Applications. IBU
2018 Anti-inflammatory and Antioxidant Effects of Captopril Compared to Methylprednisolone in L-Arginine-Induced Acute Pancreatitis. AP, iNOS, MPO, NO, TNF-alpha
2018 Captopril Attenuates Diazinon-Induced Oxidative Stress: A Subchronic Study in Rats. DZN, MDA, SOD
2018 Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model. DCM, DOX, FAM
10  2018 l-Serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier. ACE, PAMAM, Ser, SPECT/CT
11  2018 Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies. ACE, ACEIs, AD, Ang II, IL-10, iNOS, LPS, NO, RAS, TNF-alpha
12  2018 Photoluminescent coral-like carbon-branched polymers as nanoprobe for fluorometric determination of captopril. ---
13  2017 1,4-Anthraquinone: A new useful pre-column reagent for the determination of N-acetylcysteine and captopril in pharmaceuticals by high performance liquid chromatography. ANQ, HPLC, IS, NAC, TEA, tR
14  2017 Effect of Angiotensin-converting Enzyme Inhibitor on Cardiac Fibrosis and Oxidative Stress Status in Lipopolysaccharide-induced Inflammation Model in Rats. Ang, IL-6, LPS, TNF-alpha
15  2017 Investigation of the Role of a Supplementation with Taurine on the Effects of Hypoglycemic-Hypotensive Therapy Against Diabetes-Induced Nephrotoxicity in Rats. MET, STZ, Tau
16  2017 [-opioid receptors in the central nucleus of the amygdala mediate sodium intake in rats]. CeA, FURO, WD-PR
17  2016 Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study. ADMA, BM, CDDO-Me, DDAHs, eNOS, ET-1, GSH-Px, iNOS, IR, NF-kappaB, NGAL, NO, Nrf2, SOD, TAS, TEL, TOS, TT
18  2016 Inhibition of Angiotensin-II Production Increases Susceptibility to Acute Ischemia/Reperfusion Arrhythmia. AL, Ang II, CK-MB, ECG
19  2016 Micro RNA-320 as a novel potential biomarker in renal ischemia reperfusion. IR, miR, OSI, SOD, TAS, TEL, TOS
20  2016 Transformation and products of captopril with humic constituents during laccase-catalyzed oxidation: Role of reactive intermediates. HCs
21  2016 Voltammmetric Determination of Captopril Using Multiwall Carbon Nanotubes Paste Electrode in the Presence of Isoproterenol as a Mediator. CV, ISPT, SWV
22  2015 Activation of mu opioid receptors in the LPBN facilitates sodium intake in rats. FURO, LPBN
23  2015 Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. ACE, ACE2, ALI, Ang II, LPS, MAPK, PMVECs
24  2015 Interaction of gold nanoparticles mediated by captopril and S-nitrosocaptopril: the effect of manganese ions in mild acid medium. Cys, NOcap
25  2014 Effects of angiotensin converting enzyme inhibition on adiponectin levels and lipid profile in the ovariectomized-aged rats. ACE, HDL-C, LDL-C, RAS, VLDL-C
26  2014 Effects of Tulbaghia violacea Harv. (Alliaceae) rhizome methanolic extract on kidney function and morphology in Dahl salt-sensitive rats. ACEI, BP, CON, DBP, DSS, GPx, i.p, MAP, NF-kbeta, SOD, TBARS, TGF-beta, TVL
27  2014 Electropolymerization of taurine on gold surface and its sensory application for determination of captopril in undiluted human serum. CV, DPV
28  2014 Natriorexigenic effect of DAMGO is decreased by blocking AT1 receptors in the central nucleus of the amygdala. CeA, FURO, muOR, WD-PR
29  2014 The restoration of kidney mitochondria function by inhibition of angiotensin-II production in rats with acute adriamycin-induced nephrotoxicity. ADR, CK, MMP, ROS
30  2013 Cardiovascular effects of Tulbaghia violacea Harv. (Alliaceae) root methanolic extract in Dahl salt-sensitive (DSS) rats. ACE, CON, DSS, i.p, SBP, TVL
31  2013 Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophy. AC, CARV, EGCG, LOS, MDA, Que, SOD, TERT
32  2013 Facilitation of sodium intake by combining noradrenaline into the lateral parabrachial nucleus with prazosin peripherally. FURO, LPBN
33  2013 Periodontal disease reduces water and sodium intake induced by injection of muscimol into the lateral parabrachial nucleus. FURO, GABAA, IL-6, LPBN, PD, TNF-alpha
34  2012 Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice. ACE, DIO, HSL, IL-6, LCAD, LPL, MCP-1, PGC-1alpha, TLR4, UCP2
35  2012 Automated determination of total captopril in urine by liquid chromatography with post-column derivatization coupled to on-line solid phase extraction in a sequential injection manifold. EP, SI, SPE
36  2012 Involvement of brain ANG II in acute sodium depletion induced salty taste changes. ACE, ALD, Ang II, Fos-ir, FURO, RAAS
37  2012 Peptide-drug conjugate linked via a disulfide bond for kidney targeted drug delivery. ACE, CKD
38  2012 Separation methods for captopril in pharmaceuticals and biological fluids. ACE
39  2011 Automated tagging of pharmaceutically active thiols under flow conditions using monobromobimane. MBB, NAC, Pen
40  2011 Changes in taste reactivity to intra-oral hypertonic NaCl after lateral parabrachial injections of an alpha2-adrenergic receptor agonist. FURO, IO, LPBN
41  2011 Dual separation mode for simultaneous determination of antihypertensive drug combinations by high-performance liquid chromatography. AML, HCTZ, HPLC, VAL
42  2011 New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles. ACE, CDs
43  2011 S-nitrosocaptopril formation in aqueous acid and basic medium. A vasodilator and angiotensin converting enzyme inhibitor. NIT, NO, NOcap, SDS, TBN, TTABr
44  2010 Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species. ANF, Ang II, APO, ROS
45  2010 Captopril-dependent inhibition of collagen biosynthesis in cultured fibroblasts. IGF-IR
46  2010 Higher-order structures assembly of gold nanorods caused by captopril in high ionic strength solutions. ---
47  2010 Pharmacodynamic interaction of captopril with garlic in isoproterenol-induced myocardial damage in rat. ACE, GH, ISO, MI
48  2010 Quantification of captopril in urine through surface-assisted laser desorption/ionization mass spectrometry using 4-mercaptobenzoic acid-capped gold nanoparticles as an internal standard. SALDI-MS
49  2009 Adrenergic mechanisms of the Kolliker-Fuse/A7 area on the control of water and sodium intake. FURO, LPBN
50  2009 Captopril and 6-mercaptopurine: whose SH possesses higher antioxidant ability? 6-MP, 6-MPR, AAPH, DPPH
51  2009 Development and validation of an HPLC method for the simultaneous analysis of 23 selected drugs belonging to different therapeutic groups in human urine samples. ACE, ASP, CAR, CEF, DAD, DEX, DIG, DIP, ENA, FLU, FUR, KET, MET, NIF, PAR, PRE, PRO, RP-HPLC, SIL, SOT, SPI, TER, TIC, VAN
52  2009 Effect of conventional antihypertensive drugs on hypolipidemic action of garlic in rats. GH, HFD, HYD, NFD, PRO, TC, TG
53  2009 Ethyl-propiolate as a novel and promising analytical reagent for the derivatization of thiols: study of the reaction under flow conditions. Cys, EP, SI
54  2009 Rapid analysis of captopril in human plasma and pharmaceutical preparations by headspace solid phase microextraction based on polypyrrole film coupled to ion mobility spectrometry. ACE, HS-SPME-IMS
55  2008 Captopril decreases plasminogen activator inhibitor-1 in rats with ventilator-induced lung injury. Ang, PAI, PEEP, VILI
56  2008 The antihypertensive effects of quercetin in a salt-sensitive model of hypertension. Que, RAAS
57  2008 The in vivo effects of Tulbhagia violacea on blood pressure in a salt-sensitive rat model. SBP, Tvl
58  2007 Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension. PC, SHR, WKY
59  2006 Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats. ACEIs, APTT, ECLT, ENA, PER, PT, QUIN
60  2006 Enhanced plasmon resonance light scattering signals of colloidal gold resulted from its interactions with organic small molecules using captopril as an example. OSMs, PRA, PRLS
61  2006 Formulation and pharmacodynamic evaluation of captopril sustained release microparticles. CP
62  2006 Interplay between parasite cysteine proteases and the host kinin system modulates microvascular leakage and macrophage infection by promastigotes of the Leishmania donovani complex. ACE, HK, N-Pip-hF-VSPh, VL
63  2005 Chemoprotective effects of captopril against cyclophosphamide-induced genotoxicity in mouse bone marrow cells. CP, i.p, MNPCEs
64  2005 [PTEN negatively regulates isoproterenol-induced cardiac hypertrophy and effects of captopril on PTEN expression]. HW, LVEDP, LVESP, LVW
65  2004 Antithrombotic effect of captopril and enalapril in young rats. ACEIs, ECLT, ENA
66  2004 Effect of chronic exercise and Angiotensin-converting enzyme inhibition on rodent thoracic aorta. EX
67  2004 Effects of long-term captopril and L-arginine treatment on ventilation and blood pressure in obese male SHHF rats. Arg, DI
68  2003 Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure. SPIRO
69  2001 Comparison of the first dose response of fosinopril and captopril in congestive heart failure: a randomized, double-blind, placebo controlled study. ACE, Fos
70  2001 Cyclosporin A treatment for idiopathic membranous nephropathy. CR, CsA, IMN, PR
71  2001 In vitro and in vivo assessment of cellular permeability and pharmacodynamics of S-nitrosylated captopril, a nitric oxide donor. NO
72  2001 [Clinical study on therapeutic effects of treatment according to syndrome differentiation of traditional Chinese medicine combined with captopril on severe viral myocarditis complicated heart failure]. AST, CHF, LDH, SVM
73  2000 Captopril and L-arginine have a synergistic cardioprotective effect in ischemic-reperfusion injury in the isolated rat heart. ACE, CON, LA, min
74  2000 Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. ENA, MDA, SOD
75  1999 Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists. PER, SBP
76  1999 Captopril reduces the proteinuric effect of human growth hormone in adriamycin nephrosis. GH
77  1999 Effects of bile duct ligation and captopril on salt appetite and renin-aldosterone axis in rats. BDL, PA, PRA
78  1999 Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo. Ang II, chy, ISF, LV
79  1999 Inhibitory effects of captopril on hypoxia-induced proliferation and collagen synthesis in pulmonary vascular smooth muscle cells. VSMC
80  1999 Utilization of carbon disulphide for the analytical determination of betahistine hydrochloride and captopril in their pharmaceutical preparations. BHT, HPLC
81  1998 3-Bromomethyl-propyphenazone as a new derivatization reagent for high performance liquid chromatography of captopril and hydrochlorothiazide with UV-detection. BMP, HCT
82  1998 Captopril prevents nephropathy in HIV-transgenic mice. HIVAN, VEH, WT
83  1998 Captopril reduces the VE/VCO2 ratio in myocardial infarction patients with low ejection fraction. PLC, VAT, VO2
84  1998 Cholecystokinin actions in the parabrachial nucleus: effects on thirst and salt appetite. FURO, LPBN
85  1998 Inhibitory effects of captopril on c-myc expression during left ventricular hypertrophy. Ang II, BW, LV, LVH, LVW, SBP, SHR
86  1998 Inhibitory effects of S-nitrosocaptopril on vasomotor tone. PPr
87  1998 No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo. ACE, CBF, i.v, IC, NO, NTG, S-NO-Cap
88  1998 Percutaneous absorption of captopril from hydrophilic cellulose derivatives through excised rabbit skin and human skin. CMC, dec, HPC, HPMC
89  1998 Proliferation of aortic smooth muscle cells and renin-angiotensin system in SHR rats. ACE, ANG, ASMC, RAS, Sar, SF
90  1998 Salt appetite: interaction of forebrain angiotensinergic and hindbrain serotonergic mechanisms. AT1, FURO, LPBN, SFO
91  1998 [Effect of captopril on platelet cytosolic [Ca2+]i and plasma TXA2/PGI2 in renovascular hypertensive rats]. ANG, PAG, TXA2
92  1997 Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. ACEI, AT1-RA, Bay, SDR, SERCA2a
93  1997 Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. Ang II, ISF
94  1997 Effect of losartan and captopril on expression of cardiac angiotensin II AT1 receptor mRNA in rats following myocardial infarction. ANG, LOS, MI
95  1997 Effects of captopril and enalaprilat on intracellular Ca2+, Na+ contents and pH in hypoxic and reoxygenated cardiomyocytes. Ena, VER
96  1997 Regulation of hepatic angiotensinogen gene expression in nephrotic rats. Ao, DEX, EE, PRC, UAE
97  1997 [Effects of chronic administration of captopril on vascular reactivity of the rat aorta]. ACE, CTL, EDR, SHR
98  1996 Angiotensin II formation in dog heart is mediated by different pathways in vivo and in vitro. ACE, Ang II, AV
99  1996 Disparate effects of captopril on hypertension and blood vessel. BP, L-NAME
100  1996 Drug-induced alteration of endothelial permeability in the rat aorta. Potential consequences on the vessel wall. AA, CIC, CLE, EB, FUR, HCZ, HYD, IND, NIF, PER, SHR, TA